glp 1 and iih Journal club: GLP-1 receptor agonists in idiopathic intracranial hypertension Infographic: Landmark trials in Neuro-Ophthalmology—results

Wegovy is a brand-name medication approved by the Food and Drug Administration (FDA) for weight loss in certain patients, including children 12 years and older

Consumers should evaluate whether their expectations align with available evidence, whether they have consulted healthcare providers about their goals, and whether they understand the refund policies and limitations of specific products

Clinical studies show no significant side effects with long-term daily use

Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes

This research includes both animal models and human clinical trials